New insights into the treatment of asthma complicated by allergic bronchopulmonary aspergillosis [0.03%]
哮喘合并过敏性支气管肺曲霉病治疗新见解
Ritesh Agarwal,Valliappan Muthu,Inderpaul Singh Sehgal
Ritesh Agarwal
Introduction: Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder that arises in individuals with asthma or cystic fibrosis due to an exaggerated immune response to Aspergillus fumigatus. It leads to mucus p...
Network pharmacology and experimental validation of inflammation inhibition by ChuanKeZhi Injection in treating asthma [0.03%]
基于川 kezhi 注射液抗哮喘镇咳作用网络药理学及实验验证研究
Jiaying Yuan,Yuhan Wang,Bingxian Sha et al.
Jiaying Yuan et al.
Background: Chuankezhi injection (CKZ), derived from the traditional Chinese herbs Ying-Yang-Huo (Epimedium brevicornu Maxim) and Ba-Ji-Tian (Morinda officinalis F.C. How), has demonstrated remarkable clinical effects in ...
Sarah L Rhoads,Lior Seluk,Michael E Wechsler
Sarah L Rhoads
Asthma is a disease of airway inflammation and bronchial hyperresponsiveness affecting over 300 million individuals worldwide. Although described as early as 460 BC, the recognition of asthma as a disease, and the development and implementa...
Impact of the COVID-19 Pandemic on Lung Function and Treatment Decisions in Children with Asthma: A Retrospective Study [0.03%]
新冠肺炎大流行对哮喘儿童肺功能和治疗决策影响的回顾性研究
Jaqueline Abdul-Razzak,Mihaela Ionescu,Radu Diaconu et al.
Jaqueline Abdul-Razzak et al.
Background/Objectives: Asthma outcomes in children and adolescents largely depend on parental adherence to prescribed treatment plans. This study investigates how the COVID-19 pandemic influenced parental decision-making in managing their c...
Preclinical evaluation of N-acetyl-cysteine in association with liposomes of lung surfactant's lipids for the treatment of pulmonary fibrosis and asthma [0.03%]
N-乙酰半胱氨酸与肺表面活性剂脂质联合治疗肺纤维化和哮喘的临床前评估
Estefanía N Morales,Constanza Confino Malecki,Alejandro Maruri et al.
Estefanía N Morales et al.
Purpose: There is a need to generate new treatments against pulmonary diseases such as idiopathic fibrosis and asthma. N-acetylcysteine (NAC) has multiple clinical applications, but its unstable nature and route of admini...
Application of Biologics in the Treatment of Asthma in the Past Two Decades: A Bibliometric Analysis and Beyond [0.03%]
生物制剂治疗哮喘二十年的文献计量分析及展望
Zicong Zhou,Xiaoying Chen,Shixiu Liang et al.
Zicong Zhou et al.
This study aims to demonstrate the bibliometric characteristics of articles on biologics for asthma treatment over the past two decades. There were 3395 articles published in 653 journals from 91 countries/regions from January 1, 2000 to Se...
Rafał Krasowski,Katarzyna Kamińska,Katarzyna Głodek et al.
Rafał Krasowski et al.
Recent years have seen a search for more effective forms of asthma therapy, with one possible option being vitamin D supplementation. The main objective of this study was to present the current state of knowledge on the effect of vitamin D ...
Heidi Makrinioti,Bradley Chipps,Leonard B Bacharier et al.
Heidi Makrinioti et al.
Preschool asthma - one of the most common pediatric conditions - continues to spark significant debate around its management. In this article, we critically examine controversies in preschool asthma management by focusing on definition, dia...
Exploring factors associated with clinical remission in patients with severe asthma receiving anti-IL-4Rα, anti-IL-5/5R, or anti-IgE treatment [0.03%]
探究接受抗IL-4Rα、抗IL-5 / 5R或抗IgE治疗的重度哮喘患者的临床缓解因素
Shota Takahashi,Naoya Tanabe,Satoshi Marumo et al.
Shota Takahashi et al.
Background: The optimal selection of biologics is critical for achieving clinical remission (CR) in patients with severe asthma. This real-world study examined baseline prebiologic factors associated with CR in patients w...
Redaktion Facharztmagazine
Redaktion Facharztmagazine
耗时 0.27876 秒，为您在
48206918
条记录里面共找到 6204 篇文章 [XML]